Ignite Creation Date:
2025-12-24 @ 11:14 PM
Ignite Modification Date:
2026-01-01 @ 3:57 PM
Study NCT ID:
NCT00793156
Status:
UNKNOWN
Last Update Posted:
2010-02-04
First Post:
2008-11-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Randomized-Withdrawal Phase 3 Study Evaluating the Safety and Efficacy of Oral Nalfurafine HCl (AC-820)in Subjects on Hemodialysis With Uremic Pruritus (Renal Itch)
Sponsor:
Acologix, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
AC120-8231
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Dawn McGuire, MD
Old Organization:
Acologix, Inc